Equities

Bowhead Specialty Holdings Inc

BOW:NYQ

Bowhead Specialty Holdings Inc

Actions
FinancialsNon-life Insurance
  • Price (USD)28.55
  • Today's Change-0.34 / -1.18%
  • Shares traded173.23k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform2
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 4 analysts offering 12 month price targets for Bowhead Specialty Holdings Inc have a median target of 30.50, with a high estimate of 32.00 and a low estimate of 28.00. The median estimate represents a 6.83% increase from the last price of 28.55.
High12.1%32.00
Med6.8%30.50
Low-1.9%28.00

Earnings history & estimates in USD

On Aug 08, 2024, Bowhead Specialty Holdings Inc reported 2nd quarter 2024 earnings of 0.28 per share.
More ▼

Revenue history & estimates in USD

Bowhead Specialty Holdings Inc had 2nd quarter 2024 revenues of 90.09m. This missed the 90.47m consensus estimate of the 4 analysts following the company. The same period last year the company did not report revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.